BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Brain Council (EBC)
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20230704T131300
DTEND;TZID=UTC:20230704T131600
DTSTAMP:20260414T180610
CREATED:20230403T125705Z
LAST-MODIFIED:20230510T085312Z
UID:46443-1688476380-1688476560@www.braincouncil.eu
SUMMARY:EAN Congress: The role of patient representatives in the optimization of Patient Care Pathways at European level: the PKU experience
DESCRIPTION:EBC looks forward to presenting an ePoster on 'The role of patient representatives in the optimization of Patient Care Pathways at European level: the PKU experience' on 4 July 2023 at 13:13 – 13:16 at screen A2 in the Poster Area in the Exhibition Hall. \nAuthors  \nCannizzo S\, Quoidbach V\, Treacy EP\, Lange E\, Sheehan-Gilroy B\, Hagedorn T\, Turchetti G  \nIntroduction   \nIn defining and optimising patient care pathways (PCPs) the role of patient representatives (PRs) is very important; it is crucial in the contest of rare diseases where the complexity of the disorders is higher\, co-morbidity and multi-organ involvement are present\, multidisciplinary care is needed\, and patients may experience inequality in the access to specialised diagnostic/treatment procedures. In this work we have analysed the role of PRs in the design and optimization of Phenylketonuria's (PKU) PCP.       \nMethods  \nWe applied RarERN PathÓ methodology to PKU PCP within the Value of Treatment (VOT) for Rare Brain Disorders project\, coordinated by the European Brain Council. PRs of PKU Associations of Ireland and Germany were involved. The PCPs in place in centers of excellence (COE) were analysed\, and patients provided input through a semi-structured questions survey exploring organization of care and perception of criticalities when receiving healthcare services. A first draft of the optimized PCP for PKU was discussed in a plenary meeting attended by neurologists and PRs. Finally\, PRs were requested to provide additional suggestions through a second ad-hoc survey.  \nResults  \nPRs contributed to the design of an optimized PCP\, providing unique information on the main organizational challenges in COEs and on the coordination of care between COE and non-hospital care at European level.   \nConclusion  \nTo formally involve PRs in the co-design of the PCP is necessary because it allows to complement clinicians' perspective about "ranking" and "weight" of what really matters throughout the PCP. PKU case is particularly interesting in this respect.  \nAuthor details  \n\n Cannizzo Sara\, Institute of Management\, Scuola Superiore Sant'Anna\, Pisa\, Italy\n Quoidbach Vinciane\, European brain Council\, Brussels\, Belgium\n Treacy Eileen P\, National Centre for inherited Metabolic Disorders\, Mater Misericordiae University Hospital\, Dublin\, Ireland\n Eric Lange\, The European Society for Phenylketonuria and allied disorders\n5. Sheehan-Gilroy Bernadette\, PKU Association of Ireland and Munster Technological University Kerry Campus\, Tralee\, Ireland.\n6. Hagedorn Tobias\, German PKU and Allied Disorders Patients Association DIG PKU\, European Society for Phenylketonuria & Allied Disorders\n7. Turchetti Giuseppe\, Institute of Management\, Scuola Superiore Sant'Anna\, Pisa\, Italy\n\nFind out more
URL:https://www.braincouncil.eu/event/ean-congress-the-role-of-patient-representatives-in-the-optimization-of-patient-care-pathways-at-european-level-the-pku-experience/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230909
DTEND;VALUE=DATE:20230914
DTSTAMP:20260414T180610
CREATED:20220804T121643Z
LAST-MODIFIED:20230908T094911Z
UID:39372-1694217600-1694649599@www.braincouncil.eu
SUMMARY:11th IBRO World Congress of Neuroscience
DESCRIPTION:The International Brain Research Organization (IBRO) and the Spanish Neuroscience Society are excited to announce that the 11th IBRO World Congress of Neuroscience will be hosted by SENC at the Granada Exhibition and Conference Centre from 9-13 September 2023. \nSpain has a strong neuroscience tradition with the legacy of Santiago Ramón y Cajal\, and is now home to many internationally acclaimed brain research institutions including the Cajal Institute in Madrid\, the Institute of Neuroscience in Alicante\, the Institute of Neuroscience at the University of Barcelona and the Achucarro Basque Center for Neuroscience\, to name only a few. The Spanish Neuroscience Society (SENC) strengthens this extensive research network with its numerous activities and more than 1000 members. In 2018\, the Global Innovation Index also listed Spain as the 28th most innovative country in the world\, further emphasizing a strong national commitment to science and innovation. \nEBC looks forward to hosting the following sessions: \n\nSpecial Event on Fostering Global Dialogue and Partnerships in Brain Research\, 11 September 2023\, 12:10-13:10\, Room ALBENIZ + МАCHUCA\nWorkshop: How Should the Neuroscience Community Deal with Pressure to Reduce the Use of Animals in Research\, 12 September 2023\, 12:10-14:10\, Sala U2\n\nFind out more on the IBRO Congress website! \nFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/11th-ibro-world-congress-of-neuroscience/
LOCATION:Granada\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2022/08/10th-Academy-of-National-Brain-Councils-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230911T121000
DTEND;TZID=UTC:20230911T131000
DTSTAMP:20260414T180610
CREATED:20230606T153608Z
LAST-MODIFIED:20230908T091525Z
UID:47530-1694434200-1694437800@www.braincouncil.eu
SUMMARY:EBC Special Event at IBRO2023: Fostering Global Dialogue and Partnerships in Brain Research
DESCRIPTION:  \nEBC will host a Special Event on 11 September 2023 at the upcoming IBRO World Congress in Granada\, Spain\, focused on FOSTERING GLOBAL DIALOGUE AND PARTNERSHIPS IN BRAIN RESEARCH. \nEnhancing global collaboration in the domain of research and innovation is key for effectively addressing today’s societal challenges and improving the health and well-being of citizens. This is particularly true for brain disorders\, including both neurological and mental conditions\, which are widespread and highly disabling diseases that are often difficult to treat. It is crucial to explore how global research collaboration can support brain research in a meaningful way\, to the benefit of people living with brain conditions across the globe. \nIn line with its ongoing Global Partnerships in Brain Research work\, this EBC session will focus on funding\, which is often identified as a much-needed area for action in research and faces major discrepancies at the global level. A panel of global experts representing private funding\, public funding and research from high-income countries/regions (HIC) and low-middle income countries/regions (LMIC) will speak on existing funding opportunities\, address the current challenges\, and explore how funding streams that exist nationally\, regionally and internationally can be maximised for researchers. \nSpeakers: \nBradley Roberts\, Research Manager\, Wellcome Trust (UK) Confirmed \nDr George E. Barreto\, Committee Member\, IBRO Latin America Regional Committee (IBRO-LARC) and Lecturer in Cell Biology/Immunology\, University of Limerick (Ireland) Confirmed \nAntonella Autino\, Programme Manager\, Partnerships for Research and Innovation in the Mediterranean Area (PRIMA)\, Confirmed \nSandra Jurado\, Director\, Department of Cellular Neurobiology and Systems Neuroscience Institute (CSIC-UMH)\, Spain\, Confirmed \n  \nModerated by: Frédéric Destrebecq\, Executive Director\, European Brain Council (Belgium) Confirmed
URL:https://www.braincouncil.eu/event/ebc-special-event-at-ibro2023-fostering-global-dialogue-and-partnerships-in-brain-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230912T121000
DTEND;TZID=UTC:20230912T141000
DTSTAMP:20260414T180610
CREATED:20230712T120629Z
LAST-MODIFIED:20230712T120629Z
UID:48141-1694520600-1694527800@www.braincouncil.eu
SUMMARY:How Should the Neuroscience Community Deal with Pressure to Reduce the Use of Animals in Research? - Workshop at IBRO World Congress 2023
DESCRIPTION:The use of animals in scientific research remains a contentious issue. There is growing political pressure in Europe and the USA for the scientific community to transition towards ‘animal free science’. At the same time perhaps more than in any other field of biomedical research\, it is currently essential to use animals to understand the functions of the brain\, both in basic research and in drug testing. The benefits of the use of animals in research were also evident in the speedy development of the Covid-19 vaccines\, revealing that scientific advances are currently not able to replace animal use across all research and therapeutic areas. How should the neuroscience community address these potentially conflicting pressures? This topic will be addressed during this two-hour workshop by scientists who use animals in scientific research\, those who use non-animal models and a European advocacy groups\, who will provide evidence of how the neuroscience community is seeking to improve communication to the public on the use of animals in research. \nProgramme: \n12:10-12:40 Animal Research: Time to Talk!\nKirk Leech\, Executive Director\, EARA \n12:40-13:10 Response to the European Citizens’ Initiative to Phase Out Animal Experimentation in the EU by the European Brain Council\nProf. Suzanne Dickson\, President\, European Brain Council \n13:10-13:40 A Journey of Animal Neuroscience Research Advocacy in The Netherlands\nProf. Judith Homberg\, Radboud University \n13:40-14:10 Roundtable Discussion\nProf. Roger Adan\, UMC Utrecht Brain Center\nProf. Jose L. Lanciego\, Head of the Functional Neuroanatomy Basal Ganglia Lab of the Center for Applied Medical Research\, University of Navarra\nProf. Sandra Acosta Verdugo\, Universitat de Barcelona \nAll details available on the IBRO World Congress website: here.
URL:https://www.braincouncil.eu/event/how-should-the-neuroscience-community-deal-with-pressure-to-reduce-the-use-of-animals-in-research-workshop-at-ibro-world-congress-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230918T090000
DTEND;TZID=UTC:20230918T183000
DTSTAMP:20260414T180610
CREATED:20230712T082854Z
LAST-MODIFIED:20230916T152208Z
UID:48135-1695027600-1695061800@www.braincouncil.eu
SUMMARY:Global Partnerships in Brain Research - Brain Health & Research Day at the Science Summit @ UNGA78
DESCRIPTION:As part of the European Brain Council (EBC)’s Global Partnerships in Brain Research activities\, EBC\, in collaboration with the Baker Institute for Public Policy\, the Brain Capital Alliance\, the Brain Health Nexus and supporting partners will organise an event at the Science Summit at the 78th United Nations General Assembly (UNGA78) on 18 September 2023 at the Harvard Club of New York City. \nIn line with the Science Summit’s core focus of examining policy\, regulatory and financial environments needed to implement and sustain the science mechanisms required to support global scientific collaborations\, the Brain Research Day will highlight the existing partnerships\, roadmaps and potentials of extended global collaboration specifically in the brain area\, in the case of neuroscience but also in addressing brain disorders\, neurological and mental alike. \nAcross the globe\, society is facing brain challenges like never before—improving the health and well-being of citizens has become the top priority for many governments and brain health should not be left behind. Brain disorders\, neurological and mental alike\, are pervasive and pernicious diseases that are often difficult to treat. Enhancing global brain research collaboration can spur innovation and quicken effective outcomes to the benefit of people living with brain conditions everywhere. \nOver the last few years\, EBC has served as a convener for experts in the brain community to share best practices\, exchange ongoing work and align priorities to forge a joint path forward to understand and address the brain rather than in silos across continents. Two main discussions took place over the last year\, first at the SSUNGA77 in New York in September 2022 followed by a full-day event in Brussels on the occasion of Brain Awareness Week\, where it was determined that coming together and addressing global partnerships in a united\, concrete manner was an ideal and vital next step to tackle the global burden of brain disorders together. \nIn order to move past discussion and work towards explicit and tangible next steps in solidifying global efforts in brain research\, EBC proposes a full day event in order to cover a number of important areas for action\, with as many relevant actors involved\, to build towards a Call to Action and Policy Recommendations on Global Partnership in Brain Research to guide national\, regional and global policymakers towards better addressing brain health in the future\, particularly as they prepare for the post-Sustainable Development Goals era (during the Summit of the Future 2024 and the High Level Conference on the UN NCD Strategy 2025). \nView the final programme here and watch the livestream here. \nFor more information and to inquire about attendance\, please contact Stephanie Kramer\, Head of Communications\, Advocacy and Policy at EBC: stkr@braincouncil.eu
URL:https://www.braincouncil.eu/event/global-partnerships-in-brain-research-brain-health-research-day-at-the-science-summit-unga78/
LOCATION:Harvard Club of New York City\, 35 W 44th St\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/07/UNGA-Event-1.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230919T081500
DTEND;TZID=UTC:20230919T180000
DTSTAMP:20260414T180610
CREATED:20230808T134532Z
LAST-MODIFIED:20231004T093016Z
UID:48617-1695111300-1695146400@www.braincouncil.eu
SUMMARY:Brain Capital Building @ UNGA: Brain Deals to Harness AI and Drive SDG Implementation by 2030
DESCRIPTION:This conference will present the novel concept of ‘Brain Capital’ which puts a premium on cognitive skills and abilities in accomplishing socio-economic objectives. Building Brain Capital is fundamental for meeting modern societal challenges and driving innovation. The concept has been elaborated by the Neuroscience-inspired Policy Initiative launched by the OECD. Following its success\, the Brain Capital Alliance has now been formed to continue this work toward impact. Given their scope\, Brain Deals – large-scale and brain science inspired policy strategies can harness advanced AI and boost the implementation of several SDGs at the national and global levels. The model of the Brain Deal was recently noted in a Rice University’s Baker Institute for Public Policy Brief here. The event will focus on how Brain Deals can support SDG implementation by 2030. \nSee programme below: \nBrain Capital Building @ UNGA78
URL:https://www.braincouncil.eu/event/brain-capital-building-unga-brain-deals-to-harness-ai-and-drive-sdg-implementation-by-2030/
LOCATION:Steelcase WorkLife Center\, 4 Columbus Circle\, New York\, NY\, 10019\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230920T123000
DTEND;TZID=UTC:20230920T133000
DTSTAMP:20260414T180610
CREATED:20230808T103954Z
LAST-MODIFIED:20230821T074528Z
UID:48610-1695213000-1695216600@www.braincouncil.eu
SUMMARY:EBC Keynote | Value of Treatment Case Study: Chronic Pain Disorders
DESCRIPTION:During the 2023 European Pain Federation EFIC Congress\, Frédéric Destrebecq\, Executive Director of the European Brain Council\, will deliver a keynote for the session titled “VoT Chronic Pain – Health Gains and Socio-Economic Impacts of Interdisciplinary Multimodal Chronic Pain Management”. \nThe session will discuss more value-based and patient-centred care\, outline the best practice healthcare intervention\, and promote optimised healthcare interventions. \nThis will be the occasion to highlight the work done by the EBC-led Value of Treatment (VoT) project. EBC conceptualised in 2015 the Value of Treatment research framework with a first VOT study to address current unmet needs in healthcare and the increasing all-age burden of brain disorders – both neurological and mental alike. Direct healthcare and non-medical costs of brain disorders are high\, making up for 60% of the total costs (40% attributable to lost productivity) – which EBC estimated at 800 bln€/year in Europe (Gustavsson et al. in the European Neuropsychopharmacology\, 2011). All types of costs increase with the severity and the chronification of the disease. Budgetary restrictions across the EU are threatening the sustainability of the European social welfare model as a whole and make it even more important to achieve cost-effectiveness in the use of resources in health systems and its deliverables. In particular\, challenges are multiple because of the medical\, social and economic impacts of chronic disabling conditions. Together these emphasise the need for an ambitious patient-empowering research policy and an integrated\, multidisciplinary approach to brain disorders. \nAccess the preliminary agenda
URL:https://www.braincouncil.eu/event/ebc-keynote-value-of-treatment-case-study-chronic-pain-disorders/
LOCATION:EFIC 2023 Congress\, Budapest\, Hungary
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/08/Towards-Structuring-Brain-Health-Research-in-Europe-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230924
DTEND;VALUE=DATE:20230929
DTSTAMP:20260414T180610
CREATED:20230104T075541Z
LAST-MODIFIED:20230802T071941Z
UID:43930-1695513600-1695945599@www.braincouncil.eu
SUMMARY:The Congress of the European Association of Neurosurgical Societies
DESCRIPTION:We would like to welcome you all to Barcelona for the EANS2023 Annual Congress. This will take place during 24th and 28th of September\, which coincides with the finale of Barcelona’s local festivities. \nIt will be our great honour and privilege to host you in what is probably one of the most fantastic cities in Europe and the world. \nThe congress will be themed “Neurosurgery and Technology at the service of Humanity”. We are designing a program based on technological advances and how these can be effectively utilised in order to support healthcare in Low-and Middle-Income Countries. Global neurosurgery is high on the EANS agenda and we are committed to playing our role\, complementing international initiatives to help patients and colleagues in countries with less fortunate circumstances. The program will involve a special symposium which will bring together several of the key stakeholders in the field of global neurosurgery\, aiming at creating the foundations for synergy and cooperation towards our common goal. \nBarcelona will provide everyone the opportunity to enjoy the culture of the city\, the gastronomy\, and its renowned architecture. With daily after congress interactions with local historians\, tourist guides\, and sommeliers\, we can’t wait to share with you our latest discoveries of the city\, and hope to make your excursions unique\, memorable\, and indeed a great experience for everyone. \nBarcelona and EANS are looking forward to welcoming you to our 2023 Congress. \nVisit the congress website
URL:https://www.braincouncil.eu/event/the-congress-of-the-european-association-of-neurosurgical-societies/
LOCATION:Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230924T163000
DTEND;TZID=UTC:20230924T183000
DTSTAMP:20260414T180610
CREATED:20230710T144633Z
LAST-MODIFIED:20230710T144633Z
UID:48106-1695573000-1695580200@www.braincouncil.eu
SUMMARY:EBC Session at EANS2023: The need for advocacy for brain research and brain health in Europe
DESCRIPTION:This session\, led by key members of the Executive Committee\, Board and community of the European Brain Council\, will introduce the advocacy work in the brain space undertaken at the European level and explore not only the importance of the work being done but the potentials for strengthened collaboration and the needs going forward\, for the benefit of all within the brain space\, particularly with a spotlight on neurosurgery\, neurology and neurological conditions (including the clinicians that treat them and the patients that live with them). The discussion will cover the work being done by EBC and its member organisations (in particular\, EANS)\, the inclusion of the patient voice\, advocacy and policy work being done and the added value of speaking with one voice at the political level. \nProgramme to follow
URL:https://www.braincouncil.eu/event/ebc-session-at-eans2023-the-need-for-advocacy-for-brain-research-and-brain-health-in-europe/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230926T090000
DTEND;TZID=UTC:20230926T110000
DTSTAMP:20260414T180610
CREATED:20230613T082955Z
LAST-MODIFIED:20230901T140414Z
UID:47679-1695718800-1695726000@www.braincouncil.eu
SUMMARY:Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden
DESCRIPTION:Registration is now open for the virtual event Rethinking Alzheimer’s disease: Moving towards a new Alzheimer’s disease detection and diagnosis pathway in Sweden\, taking place virtually on 26 September 2023 at 09:00 – 11:00. \nThe European Brain Council (EBC)\, in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA)\, the Swedish Brain Foundation (SBF) and the Swedish Association of the Pharmaceutical Industry (LIF)\, will explore the ways we can rethink the Alzheimer’s care pathway\, particularly in the Swedish healthcare context.  \nThe virtual event follows the launch of the Rethinking Alzheimer’s Disease White Paper: Detection & Diagnosis\, looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment – MCI  – stage) and what new care pathways would need to be implemented to reach out to patients at that stage. Furthermore\, with disease modifying treatments targeting patients with MCI potentially coming to market in the near future\, it is important to see how prepared healthcare systems are to provide these new treatments.   \nThe programme will feature keynote speeches on daily life living with Alzheimer’s disease and how we can rethink the Alzheimer’s care pathway\, a panel discussion featuring key opinion leaders and experts involved in the Rethinking Alzheimer’s disease project\, and much more. Follow the EBC social media channels (Twitter\, LinkedIn) and dedicated newsletter for all the latest updates! \nDiscover the programmeRegister nowPractical information\nDate: Tuesday\, 26 September 2023\nTime: 09:00 – 11:00 (Brussels time)\nLocation: livestream\nRegistration: Please register here \nAll participants must register before attending this event. Once registered\, Zoom instructions will be sent via email closer to the date. \nRethinking Alzheimer's disease - Virtual event - Sweden - 26 September 2023 - Programme
URL:https://www.braincouncil.eu/event/rethinking-alzheimers-disease-virtual-event/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231007
DTEND;VALUE=DATE:20231011
DTSTAMP:20260414T180610
CREATED:20230104T082232Z
LAST-MODIFIED:20230104T082232Z
UID:43934-1696636800-1696982399@www.braincouncil.eu
SUMMARY:36th European College of Neuropsychopharmacology Congress
DESCRIPTION:The annual ECNP Congress is Europe’s premier scientific meeting for disease-oriented brain research\, annually attracting more than 5\,000 psychiatrists\, neuroscientists\, neurologists and psychologists from around the world. \nThis year\, the 36th ECNP Congress will take place on 7-10 October 2023 in Barcelona\, Spain. \nECNP is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. \nVisit the congress websiteFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/36th-european-college-of-neuropsychopharmacology-congress/
LOCATION:Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231010
DTEND;VALUE=DATE:20231012
DTSTAMP:20260414T180610
CREATED:20231006T114154Z
LAST-MODIFIED:20231006T134325Z
UID:49471-1696896000-1697068799@www.braincouncil.eu
SUMMARY:Side Event on Amyotrophic lateral sclerosis - The perspective of patient organisations | Conference on Rare diseases and the European Reference Networks
DESCRIPTION:The conference on Rare diseases and European reference networks will be organised under the auspices of the Spanish Presidency of the EU Council and in cooperation with the authorities of the Basque Country. It will take place on 11th October 2023 in the Euskalduna Conference Centre in Bilbao\, Spain. Interpreting will be provided from/to Spanish- German-English-French-Basque\, webstreaming in English and Spanish is foreseen. \nOn 10th October\, the day before the Conference on Rare diseases and the European Reference Networks\, the European Economic and Social Committee will organise a side event on a neurodegenerative disease Amyotrophic lateral sclerosis (ALS) in cooperation with the authorities of the Basque Country. \nThe aim of the event is to raise awareness about ALS and its impact on the life of patients and their families\, review the progress made in research to provide better treatment and better care\, and inform on actions developed at European level\, such as the EU ALS Coalition. \nVinciane Quoidbach\, Public Health and Policy Research Project Manager at EBC\, will take part in a session on “Action at European level” on 10th October at 17:00 – 18:00. She will highlight the need to pursue the intense research being conducted in many areas related to ALS\, from basic science seeking the roots of the disease to therapy development to find effective treatments. She will also share the outcomes of the EU Action Plan on Rare Diseases\, published in the framework of the Value of Treatment project\, coordinated by EBC. Follow the livestream!
URL:https://www.braincouncil.eu/event/conference-on-rare-diseases-and-the-european-reference-networks/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20231010T163000
DTEND;TZID=Europe/Helsinki:20231010T183000
DTSTAMP:20260414T180610
CREATED:20230928T124556Z
LAST-MODIFIED:20231005T120831Z
UID:49349-1696955400-1696962600@www.braincouncil.eu
SUMMARY:All in one brain: a discussion on mental health event in the European Parliament
DESCRIPTION:On the occasion of World Mental Health Day\, it is our great pleasure to invite you to the conference hosted by MEP Stelios Kympouropoulos (Greece\, EPP) entitled “All in one brain: a discussion on mental health“\, with the participation of the Commissioner for Health and Food Safety\, Ms Stella Kyriakides and the Deputy Minister of Health and psychiatrist Dr. Dimitris Vartzopoulos. The conference will take place on 10 October 2023 at the European Parliament in Brussels\, in room SPINELLI 3E2 from 16.30 to 18.30 CET and will be accessible online. \nIn the first panel\, with the participation of Ms Kyriakides and Dr. Vartzopoulos\, the political discussion will focus on the on the European Commission’s Communication on Mental Health\, published on 7 June 2023\, and the European Parliament’s Report on Mental Health\, where MEP Kympouropoulos is the shadow rapporteur for EPP. The discussion will join MEP Susana Solis Perez\, the Renew shadow rapporteur. \nThe second panel will be joined by the President of the Hellenic Brain Council\, Dr. Christina Dalla\, member of the Board of Directors at the European Brain Foundation (EBF)\, and will focus on the value of early diagnosis\, treatment\, and innovative research methods. \nIn the last panel\, the discussion will focus on digital technologies and the role they can play in mental health. Professor Elisabeth Steindl will start with a comparative analysis of the legislative framework outside the EU and comment on the new opportunities presented by the European Parliament report. Then Professor Richard Rak will present telehealth solutions and evidence-based practices for mental health\, while highlighting the importance of data collection through the latest developments in the legal framework\, including the European Health Data Space (EHDS). \nFinally\, the conference will close with the presentation of the digital application “Thymia” by CEO Ms Emilia Molimpakis. This app helps to identify mental health conditions and symptoms using voice\, movement and behavioural data. \nThe discussion will be moderated by Frédéric Destrebecq\, Executive Director of the European Brain Council (EBC). \nTo register in person please press here. To register online please press here.  \nFor more information please contact stelios.kympouropoulos-office@europarl.europa.eu \nWe are looking forward to seeing you there!
URL:https://www.braincouncil.eu/event/epevent_allinonebrain/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/09/https___cdn.evbuc_.com_images_605517589_1401864929623_1_original-1.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231026
DTEND;VALUE=DATE:20231028
DTSTAMP:20260414T180610
CREATED:20230215T093943Z
LAST-MODIFIED:20230602T061652Z
UID:45233-1698278400-1698451199@www.braincouncil.eu
SUMMARY:Brain Innovation Days: The Brain in the 21st Century
DESCRIPTION:The 3rd edition of the Brain Innovation Days team will take place on 26-27 October 2023 in Brussels (Belgium) under the overarching theme “The Brain in the 21st Century”\, centred around building resilience and better brain health for future generations and increasing our brains’ readiness to adapt to an ever-changing environment. \nFive sub-themes will inspire an exciting array of sessions throughout the two full days:\n\nResilient Brains: The Impact of Political\, Societal\, and Environmental Factors\nBoosting Brain Health and Preventing Brain Disorders\nWhat’s New? Innovative devices\, substances and medicines for brain disorders\nThe Self-Healing Brain: Use it or Lose it\nTowards a Brain Healthy 22nd Century\n\nLike previous editions\, get ready for two jam-packed days of high-level brain innovation – and this year we’re going bigger than ever! Look forward to Brain Talks\, How-To sessions\, sponsor-led satellite sessions\, the 3rd Brain Innovation Days Pitch Competition\, panel discussions with leading experts\, an Innovation Hall and countless matchmaking/networking opportunities. Take a look at the Programme and find out more! \nThe Early Bird rates are now available for registration! Benefit from this discounted rate not only for individual tickets but also for Start-up Packages and Innovation Hall fees (when abstract decisions have been made). The Early Bird Rate is available until 4 June\, so don’t wait too long. \nVisit the Brain Innovation Days website
URL:https://www.braincouncil.eu/event/brain-innovation-days-the-brain-in-the-21st-century/
LOCATION:Brussels\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20231102T090000
DTEND;TZID=Europe/Helsinki:20231102T163000
DTSTAMP:20260414T180610
CREATED:20231030T114650Z
LAST-MODIFIED:20231030T123044Z
UID:49754-1698915600-1698942600@www.braincouncil.eu
SUMMARY:Meeting on quality of child and adolescent mental health care across the WHO European Region
DESCRIPTION:On November 2\, World Health Organization’s Regional Office for Europe will hold a ‘Meeting on Quality of Child and Adolescent Mental Health Care across the WHO European Region’ in Athens. \nEBC is a member of the Pan-European Mental Health Coalition\, a partnership dedicated to improving mental health across the WHO European Region. It will target gaps in mental health services by gathering national leaders\, professionals\, members of civil society\, representatives of international organizations and experts to collaborate on bringing mental health out of the shadows and into the mainstream. \nKey priorities for the Coalition will be to transform mental health services and integrate mental health into emergency response and recovery efforts\, as well as promoting mental health and preventing mental ill health across the life course. \nMore details and the draft programme can be accessed by clicking on the following button. \nAccess the programme
URL:https://www.braincouncil.eu/event/meeting-on-quality-of-child-and-adolescent-mental-health-care-across-the-who-european-region/
LOCATION:WHO Regional Office for Europe\, Athens\, Greece
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/10/Slide-1-copy-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231107T083000
DTEND;TZID=UTC:20231107T093000
DTSTAMP:20260414T180610
CREATED:20231106T104648Z
LAST-MODIFIED:20231115T071506Z
UID:50019-1699345800-1699349400@www.braincouncil.eu
SUMMARY:Migraine: What can Europe do to avoid neglecting unmet medical need
DESCRIPTION:The Parliament Magazine\, in partnership with Abbvie\, organised an event ‘Migraine: What can Europe do to avoid neglecting unmet medical need‘\, which took place on 7 November 2023 at 08:30-09:30 in the European Parliament. \nMigraine carries an annual economic burden of €27 billion and is one of the leading causes of disability. Despite the tangible unmet need\, it is not consistently recognised as a medical burden\, especially when it comes to preventative treatment. Migraine might not be deadly but it is debilitating. \nCurrent policy proposals may offer an opportunity to address the challenges\, but a risk remains in the newly proposed unmet medical need definition. As it stands\, the definition may see migraine get deprioritised as recognition of the existing unmet need is brought into question. \nHow do we ensure that these approaches are well-defined and open the door to medical advances that leave no patient behind? \nDuring the event part of the discussion centred around the following points: \n\nHow does the inconsistent recognition of migraine as a medical burden affect preventative treatment options and patient care?\nWhat should be considered in the definition of unmet medical need to ensure patients suffering from migraine do not miss out following the revision of pharmaceutical legislation?\nWhile Brussels’ renewed commitment to mental health is welcome\, what more can the European Union do on a policy level to drive forward the commitments specific to brain health?\n\nDuring the event\, the outcomes and the policy recommendations of the Rethinking migraine project were highlighted. The aim of the project is to challenge the status quo and refreshes the European policy debate on people living with migraine\, recognises the consequences of the burdens during the COVID-19 pandemic and encourages multi-stakeholder-driven policy. The project falls under #MigraineMyBrain campaign. \nLearn more about the Rethinking migraine project
URL:https://www.braincouncil.eu/event/migraine-what-can-europe-do-to-avoid-neglecting-unmet-medical-need/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/11/one_health_europe-abbvie_eventsforce_website_banner_1440x380.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20231114T080000
DTEND;TZID=Europe/Paris:20231114T093000
DTSTAMP:20260414T180610
CREATED:20231107T081616Z
LAST-MODIFIED:20231107T082327Z
UID:50066-1699948800-1699954200@www.braincouncil.eu
SUMMARY:Good Off-Label Use Practices (GOLUP): Where are we? What next?
DESCRIPTION:The European Brain Council (EBC) with support from the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) will organise a breakfast meeting with the topic: ”Good off-label use practices: Where are we? What next?” in the European Parliament on November 14th from 08:00-09:30 CET . The event is hosted by MEP Stelios Kympouropoulos (EPP\, Greece). \nGood off-label use practices are often a necessity in areas of unmet medical need. The prevalence of off-label use in the EU in both the paediatric and adult population is high in a broad range of therapeutic areas such as rare diseases\, oncology\, psychiatry\, neurology\, in both hospitals and outpatient settings. Off-label practice poses a range of quite different challenges such as ethical and legal issues for healthcare professionals\, increased risk for patients\, patient information and consent. While not optimal but essential to address unmet medical needs\, the manner in which countries deal with the off-label use of medicines is not harmonised across the EU. \nIn 2016\, the Good Off-Label Use Practice (GOLUP) Declaration was launched\, supported by a coalition of European organisations dedicated to ensuring that high standards of patient care are upheld and that progress in medical research and innovation is achieved. The Declaration put forward the basis for a harmonised approach on when and how off-label prescription should take place across Europe. \nThe Declaration put forward the basis for a harmonised approach on when and how off-label prescription should take place across Europe: \n\nPresence of a medical therapeutic need based on a current examination of the patient by a suitably qualified health care professional;\nAbsence of authorised treatment and licensed alternatives tolerated by the patient or repeated treatment failure;\nA documented review and critical appraisal of available scientific evidence favours off-label use to respond to the unmet medical need of the individual patient;\nPatients (or their legal representative) must be given sufficient information about the medicines that are prescribed to allow them to make an informed decision;\nPresence of established reporting routes for outcomes and adverse events linked to off-label use.\n\nThis event is timely\, as the topic of repurposing has gathered attention with : \n\nthe European Medicines Agency (EMA) and the Heads of Medicines Agencies Repurposing of authorised medicines pilot launched in 2021 to support not-for-profit organisations and academia to support the repurposing of medicines as a follow-up to the European Commission’s Expert Group on Safe and Timely Access to Medicines for Patients (STAMP) discussions on a proposal for a medicines repurposing framework\,\nthe Spanish EU presidency event on the topic of ‘Repurposing and better use of clinical data’ on 27 September\, in Madrid\,\nthe revision of the pharmaceutical legislation with the Directive on medicinal products for human use looking inter alia at adverse reactions reporting in the case of off-label use products (Article 105) and unmet medical needs that are one reason and objective of the proposal (Exploratory memorandum and article 83) as well as the Regulation for the authorisation and supervision of medicinal products for human use and the expected European Commission proposal on rare diseases.\n\nThe purpose of this event is to reconnect with the GOLUP Declaration promoters\, exchange ideas and experiences to secure EU and national recognition of the Declaration with the ultimate goal to promote a common European approach for off-label use\, call for and propose EU guidelines for the good use of off-label medicinal products. \nDue to the limited number of available seats\, invitation will be done on a first come – first served basis. \nShould you be interested to attend\, please click below to secure your place. \nLearn more about the GOLUP initiative
URL:https://www.braincouncil.eu/event/good-off-label-use-practices-golup/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/11/GOLUP-Save-the-date-News-2023-2.jpg
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231122T130000
DTEND;TZID=UTC:20231122T180000
DTSTAMP:20260414T180610
CREATED:20231102T100033Z
LAST-MODIFIED:20231102T100233Z
UID:49868-1700658000-1700676000@www.braincouncil.eu
SUMMARY:SFCNS Swiss Brain Health Plan Kick-Off Meeting
DESCRIPTION:The SFCNS Swiss Brain Health Plan Kick-Off Meeting will take place on November 22\, 2023 from 13:00-18:00 at the Kunsthaus Zurich. \nThis Swiss Brain Health Plan implements the Swiss Brain Health Strategy in accordance with the EAN Brain Health Strategy\, launched by the WHO and the European Academy of Neurology EAN in 2022. \nThe joint goal is awareness creation about brain health as a whole and to initiate prevention programs. The strategic task force of the Swiss Brain Health Plan consists of the about 50 authors of the publication «The Swiss Brain Health Plan 2023-2033». \nThe Swiss Brain Health Plan will be developed further by SFCNS as it involves many specialties of the neuro field. The goal of the Kick-Off Meeting is information and awareness creation among all stakeholders i.e. politics\, hospitals\, patient organizations\, researchers\, insurances\, companies and finally the public. \nFind out more about the eventDiscover the programme
URL:https://www.braincouncil.eu/event/sfcns-swiss-brain-health-plan-kick-off-meeting/
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/11/IMNFST2315_Homepage_Banner_04.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231128T083000
DTEND;TZID=UTC:20231128T133000
DTSTAMP:20260414T180610
CREATED:20231030T150030Z
LAST-MODIFIED:20231127T072557Z
UID:49764-1701160200-1701178200@www.braincouncil.eu
SUMMARY:EBC-Spanish Presidency of the Council of the EU Event: Our Brains\, Our Future
DESCRIPTION:Our Brains\, Our FutureDate: 28 November 2023 \nTime: 08:30 – 13:30 \nLocation: Spanish Senate\, Madrid (Spain) \nProgramme (EN)Programme (ES)RegistrationSpeakersIn the framework of the Spanish presidency of the Council of the European Union\, the European Brain Council (EBC) will organize an event in the Senate of Spain this coming November 2023.  \nAmong its list of priorities\, the healthcare agenda of the Spanish Presidency places a strong emphasis on improving health outcomes and addressing pressing challenges within the European Union\, including building towards the creation of a European Health Data Space (EHDS) to improve healthcare policies and research\, disease prevention\, health promotion\, and tackling prevalent health issues\, including mental illness.  \nAcross the European Union and beyond\, society is facing health-related challenges like never before. This is particularly true for brain disorders\, neurological and mental alike\, which are widespread\, disabling\, and difficult to treat. Improving the health and well-being of citizens has become the top priority for many governments and brain health should not be left behind. In fact\, it is estimated that up to one billion people worldwide live with a neurological condition and 970 million people around the world were living with a mental health disorder as of 2019\, with anxiety and depressive disorders the most common1. In Europe alone\, approximately 60% of the population lives with a neurological condition2 and one in six citizens is affected by mental ill-health.  \nHowever\, although in the last half century\, the field of neuroscience and our knowledge of the brain has advanced considerably\, many important aspects remain extremely elusive. Clearly\, without a substantial increase in efforts and resources to promote fundamental understanding of the mechanisms that generate proper brain function\, it will be impossible to design treatments that address the real pandemic of brain health\, currently affecting a substantial part of world’s population.  Moreover\, Europe cannot ignore that this field of research holds immense appeal for a growing number of young minds\, as the brain is one of the last unexplored frontiers.  \nThe time to act is now and the Spanish Presidency priorities are a first concrete step towards increased awareness and action. Europe must take a central position in the global effort to unravel the mysteries of the brain\, both through promoting fundamental scientific research and the practical and clinically beneficial application of the knowledge that basic research generates. Enhancing collaboration in the space can fast track us towards better understanding the brain through basic research\, innovation in clinical research and treatment methods and effective outcomes to the benefit of people living with and affected by brain conditions.  \nThe European Brain Council and its wide community of members and partners has served as a convener for experts in the brain research area and health space to raise awareness\, share best practices\, exchange ongoing work\, align priorities and advocate for a real change: recognizing and prioritizing urgent intervention on the burden of brain disorders and building towards a brain healthy future for Europe and beyond.  \nThis event will demonstrate just how important this prioritization is. Crucial elements in the complex chain from basic neuroscience to patient improved outcomes will be broken down and explored. Research into the space remains crucial yet underfunded and often misunderstood and neglected\, which has a massive impact on the lives of patients. With greater prioritization and overhaul of brain research in Europe\, we have the opportunity to foster a personalized approach when developing innovative therapeutic options and better address patient relevant outcomes.  \nThis event will be bilingual. Sessions will take place in both English and Spanish – interpreters will be available for translation. \nOrganisersHis Excellency Francisco Manuel Fajardo\n \nSenate of Spain \nProf. Carlos Closa\n  \n \n  \nSpanish National Research Council \nProf. Suzanne Dickson\n \nEuropean Brain Council \nProf. Juan Lerma\n \nEuropean Brain Council \nProf. Richard Morris\n  \n \n  \nEdinburgh Futures Institute \nRosa Montero\n  \nNovelist \nProf. Rodrigo Quian Quiroga\n  \n \n  \nHospital del Mar \nProf. Giancarlo Comi\n  \n \n  \nEuropean Charchot Foundation \nDr. Usman Khan\n  \n \n  \nMotor Neurone Disease Association \nTineke Mollema\n  \n \n  \nGAMIAN-Europe \nDr. Mara Parellada\n  \n \n  \nAMITEA Programme \nDr. Paola Zaratin\n  \n \n  \nPROMS Initiative \nStephanie Hoffmann-Gendebien\n  \n \n  \nAmylyx Pharmaceuticals \nProf. José Obeso\n  \n \n  \nCentro Integral de Neurociencias AC \nDr. Mara Dierssen\n  \n \n  \nSpanish Brain Council \nDr. José Luis Lanciego\n  \n \n  \nPERC-IBRO \nCristina Maragall\n  \n \n  \nPasqual Maragall Foundation \nDr. Francisco Colomer Sanmartín\n  \n \n  \nSpanish Ministry of Science and Innovation \nFrédéric Destrebecq\n \nEuropean Brain Council \nVideo MessageFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I AcceptWith thanks to the Pasqual Maragall Foundation\, Amylyx Pharmaceuticals\, Insightec and Roche  for supporting this event. \nEvent Booklet (EN)Event Booklet (ES)Registration
URL:https://www.braincouncil.eu/event/our-brains-our-future/
LOCATION:Private: Spanish Senate\, 3 Calle de Bailén\, Madrid\, 28013\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/10/Value-of-Treatment-Collection-in-European-Psychiatry-1-1.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20231205T120000
DTEND;TZID=UTC:20231205T133000
DTSTAMP:20260414T180610
CREATED:20231121T122527Z
LAST-MODIFIED:20231121T122827Z
UID:50453-1701777600-1701783000@www.braincouncil.eu
SUMMARY:BRAINTEASER Webinar: Women in Multiple Sclerosis
DESCRIPTION:Join us for a online event that focuses on Women in Multiple Sclerosis (MS). This webinar will provide valuable insights and information about the unique challenges and experiences faced by women with MS. Gain knowledge from renowned experts in the field and hear inspiring stories from women who are managing their MS. Don’t miss this opportunity to connect with a supportive community and learn strategies to navigate the complexities of living with MS as a woman. Register now and empower yourself! \nBRAINTEASER is a data science project that seeks to exploit the value of big data\, including those related to health\, lifestyle habits\, and environment\, to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. Taking advantage of cost-efficient sensors and apps\, BRAINTEASER will integrate large\, clinical datasets that host both patient-generated and environmental data. \nRegister now!
URL:https://www.braincouncil.eu/event/brainteaser-webinar-women-multiple-sclerosis/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/03/BRAINTEASER-Website-Banner-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231206
DTEND;VALUE=DATE:20231210
DTSTAMP:20260414T180610
CREATED:20231201T135313Z
LAST-MODIFIED:20231201T135755Z
UID:50648-1701820800-1702166399@www.braincouncil.eu
SUMMARY:17th European Headache Congress Headache: Expanding the Horizon
DESCRIPTION:The 17th European Headache Congress (EHC) will take place from 6-9 December 2023\, in Barcelona\, Spain. Under the theme ‘Headache: Expanding the horizon\,’ EHC 2023 aims to spotlight the latest advancements in headache research and its management. The event’s scientific agenda will encompass diverse sessions\, educational courses\, sponsored symposia\, expert meetings\, and poster presentations. \nOn December 6th\, Michela Tinelli (London School of Economics – LSE) and Vinciane Quoidbach (European Brain Council – EBC) on behalf of the EBC-led Rethinking Migraine project will present a poster with the topic: ”Rethinking Migraine: will shifting the emphasis towards preventative treatment of migraine\, using new CGRP-targeting medicines\, be of added value to society from a health economics perspective?”. \nRegistrationMore information
URL:https://www.braincouncil.eu/event/ehc2023/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2023/12/EHC_2023_Webbanner.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240116T123000
DTEND;TZID=UTC:20240116T150000
DTSTAMP:20260414T180610
CREATED:20240112T134643Z
LAST-MODIFIED:20240112T135129Z
UID:51534-1705408200-1705417200@www.braincouncil.eu
SUMMARY:Davos Alzheimer's Collaborative Expert Roundtable
DESCRIPTION:The Davos Alzheimer’s Collaborative (DAC) will host Davos Roundtable of International Leaders to promote brain health and healthy aging\, alongside the 54th World Economic Forum Annual Meeting in Davos\, Switzerland\, January 15-19\, 2024. \nOn Tuesday\, January 16\, from 12:30-14:00 CET\, DAC will host a high-level roundtable at its Impact Venue\, just steps from the Congress Center\, bringing together prominent leaders in government\, industry\, academic\, and global communities to organize a Brain Health Ambassadors Network to extend its reach to the primary care level. \nThe roundtable will discuss brain health as an economic imperative\, the urgent need for sustained global collaboration\, and the importance of health systems strengthening to ensure healthy populations in every resource setting. Frédéric Destrebecq\, EBC Executive Director\, will take part in the roundtable discussion. \nAbout the Davos Alzheimer’s Collaborative \nLaunched at the World Economic Forum’s 2021 meeting on The Davos Agenda\, The Davos Alzheimer’s Collaborative is a multi-stakeholder partnership committed to aligning stakeholders with a new vision for our collective global response against the challenges Alzheimer’s presents to patients\, caregivers and healthcare infrastructures. Convened by The World Economic Forum and The Global CEO Initiative on Alzheimer’s Disease (CEOi) and fueled by a mission of service to the estimated 150 million families and half a billion people inevitably impacted by this disease by 2050\, DAC is a collaborative for the benefit of all people\, in all places.
URL:https://www.braincouncil.eu/event/davos-alzheimers-collaborative-expert-roundtable/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/Davos-social-share.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240116T160000
DTEND;TZID=UTC:20240116T180000
DTSTAMP:20260414T180610
CREATED:20240105T133422Z
LAST-MODIFIED:20240112T071217Z
UID:51334-1705420800-1705428000@www.braincouncil.eu
SUMMARY:The Evolution of Mental Health
DESCRIPTION:Academia\, corporate leaders\, finance executives\, and trailblazing entrepreneurs will coalesce for a dynamic set of panel discussions on The Evolution of Mental Health at the House of Trust event during the 2024 World Economic Forum! \nWe’ll explore the transformative journey of mental health\, exploring its modern evolution\, the pivotal role of businesses in promoting wellness\, the cutting-edge impact of technology and the fusion of ancient wisdom and western medicinal practices. \nBonus: Experience some of the tech for yourself at the event! \nLearn more about each panel\, here. \nPanel 1: Trends in Mental Health Innovation\nPanel 2: Mental Wellness and Stress Resilience of Business Leaders and Employees\nPanel 3: Mental Health Technology Deepdive\nPanel 4: AguilaCondor Foundation – Bridging Old & New Worlds \nEBC Executive Director\, Frédéric Destrebecq\, will take part in the Panel 1 on ‘Trends in Mental Health Innovation‘\, diving into the evolution of mental health innovations\, perceptions and investments over the last decade. \nFind out moreRegister now
URL:https://www.braincouncil.eu/event/the-evolution-of-mental-health/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/1200x628_Panels-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240117T120000
DTEND;TZID=UTC:20240117T150000
DTSTAMP:20260414T180610
CREATED:20240110T073916Z
LAST-MODIFIED:20240112T071153Z
UID:51447-1705492800-1705503600@www.braincouncil.eu
SUMMARY:Building the Mental Wealth of Nations
DESCRIPTION:The ‘Building the Mental Wealth of Nations‘ will take place in Davos\, Switzerland. \nThe event is brought to you by the Mental Wealth Initiative at the University of Sydney. Our vision is to move towards a mentally and socially thriving world. We believe the wealth of a nation is not just based on economic prosperity. National prosperity must be inclusive of social production and the mental health and wellbeing of communities \nToday we face unprecedented challenges as climate change re-shapes our borders and our boundaries. Now\, more than ever\, we need to bring people together from all industries to collaborate and find solutions to protect and enhance the mental wealth of our nations. \nThe tools and technologies of the 20th Century are inadequate to address the challenges we are currently facing and beyond. We need bold new approaches and to adopt innovative technologies and solutions\, through: \n\nEnhancing GDP by including the value of social production which underpins the economic prosperity and social cohesion of nations.\nStronger public-private partnerships to enhance brain capital\, mental health and community connectedness\nUndertaking interdisciplinary research to come up with practical solutions for global challenges\nUsing AI\, systems modelling and simulation to help leaders make effective decisions\n\nEBC Executive Director\, Frédéric Destrebecq\, will contribute to the session ‘Building Mental Wealth – threat and possible solutions’\, providing an overview about what is mental wealth and how it can be measured and improved. \nFind out more
URL:https://www.braincouncil.eu/event/building-the-mental-wealth-of-nations/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/Building-the-mental-wealth-of-nations.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240125T100000
DTEND;TZID=UTC:20240125T170000
DTSTAMP:20260414T180610
CREATED:20231208T120812Z
LAST-MODIFIED:20250214T142222Z
UID:50771-1706176800-1706202000@www.braincouncil.eu
SUMMARY:Brain Health for Society: Insights from Brain Capital
DESCRIPTION:On January 25th\, 2024\, the European Brain Council\, in partnership with Rice University Baker Institute for Public Policy and the Brain Capital Alliance\, hosted a full-day event\, Brain Health for Society: Insights from Brain Capital. Guided by Frédéric Destrebecq\, Executive Director of the European Brain Council\, this event included invited speakers and stakeholders and hosted panel discussions to motivate conversations about brain health and a shift towards a brain economy. \nThis report summarizes topics discussed at the event and outlines key strategies that emerged from the discussions held at the event. View a recording of the summit below. \nFull Day Replay | Part 1For privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I AcceptFull Day Replay | Part 2For privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I AcceptIn an ever-changing environment dominated by the influences of fast fashion\, fast food\, and social media\, and as the aging population continues to grow\, placing unprecedented strain on our social systems\, the prospect of transitioning to a brain-healthy or brain-positive economy emerges as a unique and pivotal opportunity. This necessary shift reflects the world’s increasing reliance on brain capital\, encompassing an individual’s social\, emotional\, and cognitive resources. \nThe pressing need for this shift is underscored by a concerning 59% increase in  health-related cases over the last three decades\, marking neurological conditions as the world’s leading cause of overall disease burden. The resulting brain-unhealthy or brain-negative economy\, characterized by reduced productivity\, economic insecurity\, and challenges arising from brain health disorders\, misinformation\, insufficiently targeted investment in brain science\, social media toxicity\, and environmental disparities\, necessitates the development of a comprehensive approach to ensure societal well-being. Concurrently\, global declines in democracy emphasize the urgency of supporting mental health to foster community empowerment. \nAs a diverse group of stakeholders\, including leading experts and advocates\, convened at the Brain Health for Society gathering\, their shared aim was to discuss future directions in addressing the complex landscape of global brain health. With existing brain plans providing a foundational approach to these challenges\, the collaborative discourse aims to generate key strategies for working towards a brain-healthy society\, ensuring flourishing lives in the face of evolving societal dynamics and the ever-growing cost of inaction. \n\n\n\n\nProgramme\nLOOK BACK AT THE PROGRAMME\nIncreasing life expectancy\, what’s causing the upper limit?\n\n\nOver the last three decades\, the world has witnessed a sobering 64% increase in brain health-related cases\, imposing a disproportionate burden on global disease prevalence. As populations age\, the Institute for Health Metrics and Evaluation (IHME) estimates a staggering $1 trillion in global income loss. Dr. William Heisel\, IHME’s Director of Global Services\, emphasizes the critical opportunity to shape the future by addressing brain health\, citing how the cost of inaction continues to outweigh the cost of action every day. \n\n\nTransitioning to a Brain-Healthy Economy\n\n\nA society burdened by brain health disorders experiences reduced productivity\, economic insecurity\, and challenges stemming from misinformation\, inadequate brain health investment\, social media toxicity\, and environmental disparities. Dr. Harris Eyre\, Lead in the Brain Capital Alliance\, underscores the urgency of prioritizing brain capital in political agendas. Healthy brains drive creativity\, pro-sociality\, productivity\, and social cohesion\, influencing economic structures bidirectionally. \n\n\nCurrent European Brain Plans\n\n\nAs the aging population fuels a rise in brain disorders\, current European Brain Plans\, such as those in Norway\, Switzerland\, Finland\, and Germany\, aim to manage the high costs\, alleviate suffering\, and reduce stigmas associated with brain health disorders. Prof. Claudio Bassetti\, Vice President of the European Brain Council and Lead of the Swiss Brain Health Plan\, presents the Swiss Brain Plan as a model for comprehensive approaches\, emphasizing the need for strategies that cater to both older and younger populations. \n\n\nBrain Health Clinical Innovation in Children and Youth\n\n\nExperts\, including Dr. Mikele Epperly (Global Integrated Program Leader\, Brain Health & Neurology Healthcare Ecosystems\, Roche)\, Dr. Tim Foxx (Director\, Center for School Study Councils\, University of Pennsylvania)\, Dr. Carmen Moreno (Chair\, Child and Adolescent Neuropsychopharmacology Network\, ECNP; Child and Adult Psychiatrist\, Hospital Gregorio Marañón\, Madrid\, Spain)\, and Prof. Kevin Rostasy (President\, European Paediatric Neurology Society)\, shed light on the role of education in shaping narratives\, disparities in women’s brain health\, and the necessity of child neurology in comprehensive brain plans. The panel emphasizes the magnitude of the issue\, stressing the urgency for low-cost\, accessible innovations to address youth mental health\, and highlights the financial importance of investing in children and youth brain health. Dr. Moreno’s words\, “We as a society are unhealthy and un-wealthy if the least of ours is suffering\,” capture the need for a collaborative and directed approach to building a foundation for positive mental health throughout life. \n\n\nDemocracy and Brain Health\n\n\nDr. Alexander Hudson\, Senior Advisor for the Democracy Assessment Unit at the International IDEA\, underscores the positive interaction between democracy and mental health and emphasizes the need for participation and mental health support to bolster democracy. However\, declines in democracy pose challenges globally\, creating a pressing need for a collective and multi-layered effort to support mental health and democratic processes. \n\n\nBrain Science for Flourishing Lives\n\n\nDr. Dennis Pamlin\, Executive Director of The Net-Zero Compatibility Initiative at Mission Innovation\, advocates for an expanded innovation agenda to promote flourishing lives\, emphasizing the role of brain health in sustainable development. He promotes a shift from fast-paced trends to prioritizing the human right to creativity and well-being. Pamlin calls for targeted approaches and user-friendly tools for investors to support this shift. \n\n\nBrain Health Clinical Innovation in Mid- and Late-Life\n\n\nExperts\, including Dr. Paulo Fontoura (Global Head and SVP Neuroscience\, Immunology\, Ophthalmology\, Infectious and Rare Diseases\, Roche)\, Dr. Maria Teresa Ferretti (Affiliated researcher\, Center for Alzheimer Studies\, Karolinska Institut; External teacher (Privat Dozent)\, Medical university of Vienna; Clinical Development Lead\, Syntropic Medical)\, Prof. Peter Falkai (Treasurer\, European Brain Council; Past President\, European Psychiatric Association)\, Dr. Quazi Haque (Chief Medical Officer\, Elysium Healthcare & Global Mental Health & Brain Science CoP Lead\, Ramsay Healthcare)\, and Prof. Craig Ritchie (CEO and Founder\, Scottish Brain Sciences)\, discuss the invisible costs of inadequate brain health and highlight the significance of reducing the burden of chronic disease for better brain health. The group urges personalized\, targeted care for brain health\, resilience training\, and systematic change for early intervention to elevate brain health both as a priority of its own and as a part of the wider approach to a healthy life. \n\n\nThe Patient Perspective\n\n\nDr. Orla Galvin\, Executive Director of the European Federation of Neurological Associations\, addresses the underfunding and stigmatization of neurology globally\, emphasizing the vast societal and economic impact on individuals with neurological conditions. Brain skills\, including resilience and creativity\, unite neurology patients\, promoting holistic support for the development of such skills. \n\n\nAdvances from Denmark: Improving health in the context of public-private partnerships\n\n\nDr. Tina Hjortlund\, Head of Global Public Affairs and DE&I Officer at Lundbeck\, suggests the public sector cannot address health care challenges alone. She emphasizes the shared responsibility across public and private sectors to find innovative solutions and enhance healthcare solutions that prioritize mental health. Dr. Hjortlund encourages utilizing existing models of public-private partnerships to develop new collaborative partnerships guided by evidence-based decision-making in alignment with national strategies and in support of political priorities. \n\n\nNext Generation Brain Plans\n\n\nThis panel\, moderated by  Paweł Świeboda\, Founder of Neurocentury\,  in discussion with Marco Mohwinckel (Mental health and health technology investor and advisor)\, Prof. Peter Falkai (Treasurer\, European Brain Council; Past President\, European Psychiatric Association)\,  Azad Bonni (SVP Roche pRED Global Head of Neuroscience & Rare Diseases\, Roche)\, and Henrik Peersen (Secretary General\, Hjernerådet (Norwegian Brain Council)\, delves into experiences and challenges of comprehensive brain health plans\, highlighting insights from Norway\, Germany\, and an industry perspective. Calls for concrete\, measurable goals\, research collaboration between healthcare systems\, governments\, and private entities\, and flexible approaches underscore the need for constant solutions to address evolving challenges in brain health. The experts in the panel discuss the potential benefits and limitations of developing a European Brain Plan adapted at a national level. \n\n\nScaling what works to add years to life and life to years\n\n\nDr. Kana Enomoto\, Director of Brain Health at McKinsey Health Institute\, addressed the private sector’s role in mental health\, advocating for investments in effective and holistic approaches to health that encompass physical\, mental\, and spiritual well-being. Her call to action\, urging to “square the curve” by enhancing average quality and global life expectancy\, is coupled with a visionary goal of 90/90/90 —screening\, evidence-based treatment\, and symptom management—for all individuals\, with recovery as the expected outcome. This visionary approach sets the stage for transformative change in mental health. \n\n\nBrain Capital and Impact Investing \n\n\nExperts\, including Dr. Shiva Dustdar (Head\, European Investment Bank Institute)\, Dr. Ekkehard Ernst (Chief\, Macroeconomic Policy Unit\, International Labour Organization and President\, Geneva Macro Labs)\, Dr. Nathalie Hilmi (Head of Environmental Economics\, Center for Science\, Monaco)\, and Christian Schuetz (Director – Investments / ESG\, Golding Capital Partners) explored the intersection of economic value\, cognitive abilities\, and brain health\, emphasizing the interconnectedness of healthy cognitive development\, ecological significance\, and economic security with panel moderator\, Dr. Rym Ayadi (Founder and President\, Euro-Mediterranean Economists Association). The panel calls for collaboration and clarity in communication\, stressing the importance of bridging the gap between societal challenges and financial solutions. The panel discusses the idea of impact investing for brain capital\, explaining that brain capital is in a growth phase and requires three main characteristics to propel it towards success: fast product-scalability\, ability to be profitable for both the manufacturer and the customer\, and ability to tap into large markets. The panel concludes with a call to unify groups of experts and policymakers to create central arguments that strategically explain the financial and societal benefit of brain capital to stakeholders capable of driving change in society. \n\n\nPatient Prevention\n\n\nGeorge Vrandenburg\, Chairman of the Davos Alzheimer’s Collaborative\, discusses the patient’s role in developing solutions\, emphasizing the necessity of practical and concrete plans at the primary care level to be financed by the World Bank. \n\n\nPathways Forward for Brain Capital\n\n\nThe final panel\, including Dr. Shiva Dustdar (Head\, European Investment Bank Institute)\, Dr. Harris Eyre\, (Lead\, Brain Capital Alliance) and Michael Oberreiter (Head of Global Access\, Roche) focuses on the conceptualization\, implementation\, sequencing\, and involvement of various stakeholders in the Brain Capital agenda. Highlighting the need to integrate the brain lens into the existing EU funding framework\, the panelists call for better documentation and evidence to bolster the existing investment in the brain economy. Dr. Oberreiter stresses the importance of proving the economic return on investing in brain health\, proposing the creation of a Brain Capital index to measure the competitiveness of nations and implementation of a similar index in workplaces. Dr. Eyre proposes a transition to a brain economy and advocates for engaging G7 and G20\, forming an inter-parliamentary brain capital task force\, and initiating specific brain health plans and investments. The emphasis is on creating a compelling case for brain health as an investment\, aligning incentives\, and involving a diverse set of actors for impactful change. \n\n\nPriorities to address:\n\n\nComprehensive and Flexible Brain Health Plans: Develop clear objectives and concrete measures for comprehensive brain health plans\, focusing on effectiveness and measurability. Adopt a flexible approach involving both national and European-level elements to address evolving challenges in brain health comprehensively. \nInvestment in Brain Capital: Prioritize brain capital in political agendas\, recognizing the bidirectional relationship between healthy brains and economic prosperity. Integrate brain health into existing EU funding frameworks\, documenting and evidencing significant investments in the brain economy. \nCollaborative Research and Innovation: Encourage collaboration at national and international levels\, engaging diverse stakeholders such as scientists\, policymakers\, healthcare innovators\, and impact investors\, for research innovation\, redefinition of economic models\, and access to digital data in brain health. Engage the private sector through public-private partnerships\, encouraging evidence-based decision-making and patient-centric solutions. \nBrain Capital Index: Develop a Brain Capital index to measure the competitiveness of nations and prove the economic return on investing in brain health. Implement a similar system into workplaces\, providing financial incentive to support brain health. \nThe conference concluded with a compelling call to action for a collective effort in redefining global approaches to brain health\, urging governments\, industries\, and individuals to prioritize mental well-being for a healthier\, sustainable future. \n\nContinue the ConversationEBC Brain Awareness Week Event 2024: No Health Without Brain Health07.03.2024 @ 11:00 - 13:00Neuroscience and Society: A Life Course Approach to Brain Health – Science Summit of 79th United Nations General Assembly19.09.2024 - 20.09.2024Brain Innovation Days13.11.2024 - 14.11.2024About the authorsOlivia Nail-Beatty is a senior neuroscience student pursuing a five years master in Bioscience and Health Policy at Rice University \nStephanie Kramer is the Deputy Executive Director at the European Brain Council \nFrédéric Destrebecq  is the Executive Director at the European Brain Council and European Brain Foundation \nKaitlin May is the Program Manager\, Center for Health and Biosciences at Baker Institute \nPartnersWith thanks to Roche for supporting this event.
URL:https://www.braincouncil.eu/event/brain-health-for-society-insights-from-brain-capital/
LOCATION:Hyperion Hotel\, Messepl. 12\, Basel\, 4058\, Switzerland
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/12/No-health-without-brain-health-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240214
DTEND;VALUE=DATE:20240216
DTSTAMP:20260414T180610
CREATED:20240119T084046Z
LAST-MODIFIED:20240212T094916Z
UID:51714-1707868800-1708041599@www.braincouncil.eu
SUMMARY:Bio-Neuroscience
DESCRIPTION:ProgrammeRegistrationMore InformationConvened by-invitation\, Bio-Neuroscience is a high level\, boutique gathering of key thought leaders\, innovators and decision-makers from all key stakeholder groups crucial to the discovery\, development and market launch of novel therapeutics and breakthrough platforms and technologies. \nBio-Neuroscience is the global partnering and investment summit for global leaders and innovators in CNS neuroscience and psychiatric drug discovery\, development\, platforms and technologies. High level access\, serious\, sustained engagement\, discussion and networking with key stakeholders. Sharing models\, lessons learned\, solutions\, ways forward and best practices. A truly curated and unique summit to facilitate business and accelerate innovation.  \nFrédéric Destrebecq\, EBC Exectuive Director\, will take part in a panel discussion on ‘CNS Neurosciences and Psychiatry – the need for a new generation of novel therapeutics and the policy and ecosystem requirements to accelerate development‘\, set to take place on 14 February 2024 at 09:15-09:45. \nThe members of the EBC network can benefit from 20% discount code. If you are part of our network\, please get in contact with us at advocacy@braincouncil.eu. \nCo-OrganisersProgrammeRegistrationMore Information
URL:https://www.braincouncil.eu/event/bio-neuroscience/
LOCATION:Rosarium Amstelpark\, Amstelpark 1 Europaboulevard\, Amsterdam\, 1083\, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/1704952529471.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240224T090000
DTEND;TZID=UTC:20240224T161500
DTSTAMP:20260414T180610
CREATED:20231222T113218Z
LAST-MODIFIED:20231222T113359Z
UID:51050-1708765200-1708791300@www.braincouncil.eu
SUMMARY:Brain in Sport: Preventing & Managing Concussion and its Consequences
DESCRIPTION:The European Brain Foundation (EBF)\, in partnership with the French Rugby Federation\, Rugby Europe\, and World Rugby\, will host its first event on the subject of Brain in Sport dedicated to concussion\, providing the most comprehensive information possible on concussion and its treatment\, including key opinion leaders and experts in field to share state of play in a medico-scientific perspective and testimonies from players\, to better understand where the risk of concussion and head trauma in a particular sport exists and how it best to manage it. \nInformation & ProgrammeRegister
URL:https://www.braincouncil.eu/event/brain-in-sport-preventing-managing-concussion-and-its-consequences/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/12/EBF-EVENT.png
ORGANIZER;CN="European Brain Foundation":MAILTO:office@brainfoundation.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240228
DTEND;VALUE=DATE:20240303
DTSTAMP:20260414T180610
CREATED:20240209T150137Z
LAST-MODIFIED:20240209T150535Z
UID:52454-1709078400-1709423999@www.braincouncil.eu
SUMMARY:International Newborn Brain Conference
DESCRIPTION:The International Newborn Brain Conference (INBBC)  provides a state-of-the-art forum for presentation and discussion of current research and clinical practice in newborn brain care\, including diagnosis\, monitoring and management strategies to optimize neurodevelopmental outcome. It explores the means to understand\, monitor\, protect and treat the newborn brain. The INBBC provides continuing medical education to multidisciplinary professionals working to improve the neurological and developmental health outcomes of premature and high-risk newborns. The Conference will take place on 28 February – 2 March 2024 in Cork (Ireland). \nLearn more
URL:https://www.braincouncil.eu/event/international-newborn-brain-conference/
LOCATION:Cork\, Ireland
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/02/event_1707415727550.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240229T093000
DTEND;TZID=UTC:20240229T140000
DTSTAMP:20260414T180610
CREATED:20240118T084326Z
LAST-MODIFIED:20240318T140409Z
UID:51691-1709199000-1709215200@www.braincouncil.eu
SUMMARY:Towards a Rare Brain Disease Ecosystem
DESCRIPTION:The main purpose of Rare Disease Day is to raise awareness about rare diseases and their impact on the lives of those affected. Encouraging policy changes can influence policymakers to create policies and regulations that better address the needs of people with rare diseases\, including improved access to diagnosis and treatment.  \nTo raise awareness on rare brain disease\, this event\, organised by the European Brain Council\, will bring together researchers\, clinicians\, persons living with brain disease and industry to share their perspectives and priorities in the rare brain disease research\, care\, and policy space. This will result in the 2024 strategic plan for the EBC rare brain disease ecosystem. \nPractical information\nDate: Thursday\, 29 February 2024\nTime: 09:30 – 14:00 (Brussels time)\nLocation: University Foundation (Francqui Room)\, Rue d’Egmont 11\, 1000 Brussels\, Belgium  & livestream\nRegistration for online attendance: register here\nRegistration for in-person attendance: please contact us at comm@braincouncil.eu \nAll participants must register before attending this event. Once registered for the online participation\, Zoom instructions will be sent via email closer to the date. \nDiscover the programme & the speakersRegister nowRare Disease Day 2024 - Programme & Speakers
URL:https://www.braincouncil.eu/event/towards-a-rare-brain-disease-ecosystem/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2024/01/Towards-a-Rare-Brain-Disease-Ecosystem-2024-1-1-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240305
DTEND;VALUE=DATE:20240310
DTSTAMP:20260414T180610
CREATED:20231128T125501Z
LAST-MODIFIED:20231128T131248Z
UID:50553-1709596800-1710028799@www.braincouncil.eu
SUMMARY:Alzheimer's and Parkinson's Diseases Conference
DESCRIPTION:The Alzheimer’s and Parkinson’s Diseases Conference (AD/PD™) will take place on 5-9 March 2024 in Lisbon (Portugal) and virtually. \nThe AD/PD™ Conference is where the brightest minds gather to explore the latest research\, clinical trials\, and treatments for Alzheimer’s and Parkinson’s. From uncovering groundbreaking discoveries to sharing the latest developments in treatments. \nThe Conference will give you the amazing opportunity to meet and hear what the leading international experts are working on\, discuss the latest news and trends in the field\, and present in front of them your own work and gain valuable feedback. \nThe AD/PD™ Conference has grown to be one of the leading events in the field of neurodegenerative disorders with over 4\,100 participants from 61 countries and over 2\,000 abstracts in 2023. \nFind out moreFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/alzheimers-and-parkinsons-diseases-conference/
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/11/ADPD-2024_banner_800x200.png
END:VEVENT
END:VCALENDAR